400
Participants
Start Date
March 31, 2007
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)
PEGASYS: 180 microgram per week (Injection) Plus Ribavirin: 800 milligram per day (PO)
PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin)
PEGASYS: 180 microgram per week (Injection) Plus Ribavirin: \[=\<75 kg: 1000 mg; \>75 kg: 1200 mg per day (PO)\]
Baqiyatallah Research Center for Gastroenterology and Liver Diseases, Tehran
Baqiyatallah Research Center for Gastroenterology and Liver Diseases
OTHER
Tehran Hepatitis Center
OTHER
Guilan University of Medical Sciences
OTHER
Tabriz Research Center for Gastroenterology and Liver Diseases
UNKNOWN
Shahid Beheshti University of Medical Sciences
OTHER
Iran University of Medical Sciences
OTHER
Baqiyatallah Medical Sciences University
OTHER